{"id":795014,"date":"2024-12-16T08:04:58","date_gmt":"2024-12-16T13:04:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/"},"modified":"2024-12-16T08:04:58","modified_gmt":"2024-12-16T13:04:58","slug":"aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/","title":{"rendered":"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card"},"content":{"rendered":"

<\/p>\n

AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR<\/span>\u201d All Four Incumbent Board Members on the WHITE<\/span> Universal Proxy Card<\/b><\/p>\n

Urges Shareholders to Ensure Their Voices Are Heard and to Protect Their Investment by Supporting Current Board<\/i><\/p>\n

Believes Incumbent Board is Best Positioned to Continue Overseeing the Clinical Development of Ampligen and Deliver Long-Term Value for All Shareholders<\/i><\/p>\n

Warns Shareholders that the Activist Group\u2019s Self-Interested Agenda Could Put AIM\u2019s Progress at Risk<\/i><\/p>\n

Highlights the Activist Group\u2019s Lack of a Plan and Persistent Attempts to Mislead Shareholders<\/i><\/p>\n

OCALA, Fla.–(BUSINESS WIRE<\/a>)–
\nAIM ImmunoTech Inc. (NYSE American: AIM) (\u201cAIM\u201d or the \u201cCompany\u201d) today issued the following statement in connection with the upcoming 2024 Annual Meeting of Stockholders (the \u201cAnnual Meeting\u201d), presently scheduled for December 17, 2024 at 11:00 a.m. ET:<\/p>\n

\nAIM urges shareholders to protect their investment and the Company’s future by voting on the WHITE<\/span><\/b> universal proxy card \u201cFOR<\/span><\/b>\u201d all four current members of our Board of Directors (the \u201cBoard\u201d).<\/p>\n

\nAIM is confident that its incumbent directors have the right backgrounds and relevant expertise to continue driving forward our strategy to realize long-term value for all shareholders. We have significant momentum in our clinical development programs \u2013 especially in areas of critical unmet need \u2013 that is laying the groundwork for commercialization opportunities. The partnerships we have forged with large biopharmaceutical companies and world-class research organizations are a testament to the potential of our lead drug candidate, Ampligen.<\/p>\n

\nAllowing the group of activist investors (the \u201cActivist Group\u201d) to take control of the Board could jeopardize this progress, give them access to AIM\u2019s capital to reimburse themselves more than $5 million dollars and destroy the chances of near-term value creation for shareholders. The Activist Group lacks a clear plan for AIM \u2013 as leading proxy advisory firms Institutional Shareholder Services Inc. and Glass, Lewis & Co., LLC both concluded \u2013 and shareholders should not be taken in by their desperate eleventh hour attempts to make it seem otherwise.<\/p>\n

\nShareholders can Safeguard AIM by voting \u201cFOR\u201d<\/b> all four of the Board\u2019s incumbent candidates \u2013 Stewart L. Appelrouth<\/b>, Nancy K. Bryan<\/b>, Thomas K. Equels<\/b> and Dr. William M. Mitchell<\/b> \u2013 on the WHITE<\/span><\/b> universal proxy card.<\/p>\n

\nIt is extremely important that shareholders vote as soon as possible \u2013 no matter how many shares they own.<\/p>\n

Given that the Annual Meeting is quickly approaching, shareholders are encouraged to vote by internet according to the instructions on their WHITE universal proxy card.<\/span><\/b><\/p>\n

\nIf shareholders have any questions or require any assistance in voting their shares, please contact our proxy solicitor:<\/p>\n

Sodali & Co.
\n
<\/b>430 Park Avenue, 14th Floor
\n
New York, NY 10022<\/p>\n

Shareholders may call toll-free:<\/b> (800) 662-5200
\n
Banks, Brokers, Trustees, and Other Nominees Call Collect:<\/b> (203) 658-9400
\n
Email:<\/b>AIM@investor.Sodali.com<\/a><\/p>\n

\nFor more information visit: www.SafeguardAIM.com<\/a>.<\/p>\n

\n***<\/p>\n

About AIM ImmunoTech Inc.<\/b><\/p>\n

\nAIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company\u2019s lead product is a first-in-class investigational drug called Ampligen\u00ae<\/sup> (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system.<\/p>\n

\nFor more information, please visit aimimmuno.com<\/a> and connect with the Company on X<\/a>, LinkedIn<\/a>, and Facebook<\/a>.<\/p>\n

Forward-Looking Statements<\/b><\/p>\n

\nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the \u201cPSLRA\u201d). Words such as \u201cmay,\u201d \u201cwill,\u201d \u201cexpect,\u201d \u201cplan,\u201d \u201canticipate,\u201d \u201ccontinue,\u201d \u201cbelieve,\u201d \u201cpotential,\u201d \u201cupcoming\u201d and other variations thereon and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements. Many of these forward-looking statements involve a number of risks and uncertainties. Data, pre-clinical success and clinical success seen to date does not guarantee that Ampligen will be approved as a treatment or therapy for any diseases or conditions. The Company urges investors to consider specifically the various risk factors identified in its most recent Annual Report on Form 10-K, and any risk factors or cautionary statements included in any subsequent Quarterly Report on Form 10-Q or Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d). You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Among other things, for those statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the PSLRA. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof.<\/p>\n

Important Additional Information<\/b><\/p>\n

\nThe Company, its directors and executive officers, Peter W. Rodino, III and Robert Dickey, IV, are deemed to be \u201cparticipants\u201d (as defined in Section 14(a) of the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from the Company\u2019s stockholders in connection with the Annual Meeting. The Company filed its definitive proxy statement (the \u201cDefinitive Proxy Statement\u201d) and a WHITE <\/b>universal proxy card with the SEC on November 4, 2024 in connection with such solicitation of proxies from the Company\u2019s stockholders. STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ SUCH DEFINITIVE PROXY STATEMENT, ACCOMPANYING WHITE UNIVERSAL PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY CONTAIN IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING.<\/b> The Definitive Proxy Statement contains information regarding the identity of the participants, and their direct and indirect interests, by security holdings or otherwise, in the Company\u2019s securities and can be found in the section titled \u201cPrincipal Stockholders\u201d of the Definitive Proxy Statement and available here<\/a>. Information regarding subsequent changes to their holdings of the Company\u2019s securities can be found in the SEC filings on Forms 3, 4, and 5, which are available on the Company\u2019s website available here<\/a> or through the SEC\u2019s website at www.sec.gov<\/a>. Stockholders will be able to obtain the Definitive Proxy Statement, any amendments or supplements thereto and other documents filed by the Company with the SEC at no charge at the SEC\u2019s website at www.sec.gov<\/a>. Copies will also be available at no charge at the Company\u2019s website at https:\/\/aimimmuno.com\/sec-filings\/<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20241215458142\/en\/<\/a><\/span><\/p>\n

Investor Contact:
\n<\/b>
JTC Team, LLC
\n
Jenene Thomas
\n
908-824-0775
\n
AIM@jtcir.com<\/a><\/p>\n

Media Contact:
\n<\/b>
Longacre Square Partners
\n
Joe Germani \/ Miller Winston
\n
AIM@longacresquare.com<\/a><\/p>\n

KEYWORDS:<\/b> Florida United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Research Finance Clinical Trials Professional Services Biotechnology Health Pharmaceutical Science Oncology<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card Urges Shareholders to Ensure Their Voices Are Heard and to Protect Their Investment by Supporting Current Board Believes Incumbent Board is Best Positioned to Continue Overseeing the Clinical Development of Ampligen and Deliver Long-Term Value for All Shareholders Warns Shareholders that the Activist Group\u2019s Self-Interested Agenda Could Put AIM\u2019s Progress at Risk Highlights the Activist Group\u2019s Lack of a Plan and Persistent Attempts to Mislead Shareholders OCALA, Fla.–(BUSINESS WIRE)– AIM ImmunoTech Inc. (NYSE American: AIM) (\u201cAIM\u201d or the \u201cCompany\u201d) today issued the following statement in connection with the upcoming 2024 Annual Meeting of Stockholders (the \u201cAnnual Meeting\u201d), presently scheduled for December 17, … <\/p>\n

Continue reading “AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-795014","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card Urges Shareholders to Ensure Their Voices Are Heard and to Protect Their Investment by Supporting Current Board Believes Incumbent Board is Best Positioned to Continue Overseeing the Clinical Development of Ampligen and Deliver Long-Term Value for All Shareholders Warns Shareholders that the Activist Group\u2019s Self-Interested Agenda Could Put AIM\u2019s Progress at Risk Highlights the Activist Group\u2019s Lack of a Plan and Persistent Attempts to Mislead Shareholders OCALA, Fla.–(BUSINESS WIRE)– AIM ImmunoTech Inc. (NYSE American: AIM) (\u201cAIM\u201d or the \u201cCompany\u201d) today issued the following statement in connection with the upcoming 2024 Annual Meeting of Stockholders (the \u201cAnnual Meeting\u201d), presently scheduled for December 17, … Continue reading "AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-16T13:04:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card\",\"datePublished\":\"2024-12-16T13:04:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/\"},\"wordCount\":1106,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/\",\"name\":\"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2024-12-16T13:04:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/","og_locale":"en_US","og_type":"article","og_title":"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card - Market Newsdesk","og_description":"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card Urges Shareholders to Ensure Their Voices Are Heard and to Protect Their Investment by Supporting Current Board Believes Incumbent Board is Best Positioned to Continue Overseeing the Clinical Development of Ampligen and Deliver Long-Term Value for All Shareholders Warns Shareholders that the Activist Group\u2019s Self-Interested Agenda Could Put AIM\u2019s Progress at Risk Highlights the Activist Group\u2019s Lack of a Plan and Persistent Attempts to Mislead Shareholders OCALA, Fla.–(BUSINESS WIRE)– AIM ImmunoTech Inc. (NYSE American: AIM) (\u201cAIM\u201d or the \u201cCompany\u201d) today issued the following statement in connection with the upcoming 2024 Annual Meeting of Stockholders (the \u201cAnnual Meeting\u201d), presently scheduled for December 17, … Continue reading \"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-16T13:04:58+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card","datePublished":"2024-12-16T13:04:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/"},"wordCount":1106,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/","name":"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en","datePublished":"2024-12-16T13:04:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20241215458142r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-reminds-shareholders-to-vote-for-all-four-incumbent-board-members-on-the-white-universal-proxy-card\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AIM ImmunoTech Reminds Shareholders to Vote \u201cFOR\u201d All Four Incumbent Board Members on the WHITE Universal Proxy Card"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/795014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=795014"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/795014\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=795014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=795014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=795014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}